Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis

被引:32
作者
Venkatesh, Preethi G. K. [1 ]
Jegadeesan, Ramprasad [1 ]
Gutierrez, Norma G. [1 ]
Sanaka, Madhusudhan R. [1 ]
Navaneethan, Udayakumar [1 ]
机构
[1] Cleveland Clin, Dept Gastroenterol, Inst Digest Dis, Cleveland, OH 44106 USA
关键词
Flat dysplasia; Low grade dysplasia; Ulcerative colitis; Primary sclerosing cholangitis; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; COLONOSCOPIC SURVEILLANCE; PRACTICE GUIDELINES; RISK; MORTALITY; ADULTS;
D O I
10.1016/j.crohns.2013.02.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: Patients with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) are at increased risk of colon cancer. The aim of this study was to determine the natural history of LGD and its progression to high grade dysplasia (HGD)/colorectal cancer (CRC) in PSC-UC patients. Methods: Ten PSC-UC patients with LGD who underwent surveillance colonoscopy from 1996 to 2011 were evaluated. Raised dysplasia was defined as a discrete raised lesion located in an area involved by either quiescent or active colitis that was endoscopically resected, while flat dysplasia was defined as the absence of documentation of a raised lesion. Results: Of the 10 patients with LGD, 3 (30%) progressed to raised HGD over a mean follow-up of 13 +/- 11 months. Three of 10 patients had initial raised LGD while 7 had flat LGD. The location of HGD was in the proximal colon in all 3 patients. However all 3 patients who progressed to HGD had initial dysplasia located in the distal colon and had flat morphology. The incidence rate for detection of HGD/CRC was 9.4 cases per 100 person years at risk. Patients with LGD with flat morphology had an incidence rate of 17.8 cases per 100 person years at risk. HGD occurred more frequently within the first year of initial detection of LGD (23.5 per 100 patient years of follow-up). Conclusions: One-third of patients with LGD progressed to HGD/CRC in PSC-UC. Most patients progress within the first year of diagnosis of LGD supporting early colectomy in PSC-UC patients with LGD. (C) 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:968 / 973
页数:6
相关论文
共 23 条
[1]  
BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1002/hep.1840220511
[2]   COLONOSCOPIC SURVEILLANCE REDUCES MORTALITY FROM COLORECTAL-CANCER IN ULCERATIVE-COLITIS [J].
CHOI, PM ;
NUGENT, FW ;
SCHOETZ, DJ ;
SILVERMAN, ML ;
HAGGITT, RC .
GASTROENTEROLOGY, 1993, 105 (02) :418-424
[3]   High lifetime risk of cancer in primary sclerosing cholangitis [J].
Claessen, Marian M. H. ;
Vleggaar, Frank P. ;
Tytgat, Kristien M. A. J. ;
Siersema, Peter D. ;
van Buuren, Henk R. .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :158-164
[4]  
Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145
[5]   The risk of colorectal cancer in ulcerative colitis: a meta-analysis [J].
Eaden, JA ;
Abrams, KR ;
Mayberry, JF .
GUT, 2001, 48 (04) :526-535
[6]   Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease [J].
Itzkowitz, SH ;
Present, DH .
INFLAMMATORY BOWEL DISEASES, 2005, 11 (03) :314-321
[7]   Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years [J].
Jess, Tine ;
Simonsen, Jacob ;
Jorgensen, Kristian Tore ;
Pedersen, Bo Vestergaard ;
Nielsen, Nete Munk ;
Frisch, Morten .
GASTROENTEROLOGY, 2012, 143 (02) :375-+
[8]   Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis?: A population based case control study [J].
Karlén, P ;
Kornfeld, D ;
Broström, O ;
Löfberg, R ;
Persson, PG ;
Ekbom, A .
GUT, 1998, 42 (05) :711-714
[9]  
Kornbluth A, 1997, AM J GASTROENTEROL, V92, P204
[10]   Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee [J].
Kornbluth, Asher ;
Sachar, David B. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (03) :501-523